Effects of isoflavones on breast density in pre-and post-menopausal women: A systematic review and meta-analysis of randomized controlled trials

Human Reproduction Update

Volumn 16, Issue 6, 2010, Pages 745-760

  Hooper, Lee ^a   Madhavan, Giri ^a   Tice, Jeffrey A ^b   Leinster, Sam J ^a   Cassidy, Aedín ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer risk; Isoflavone; Mammographic density; Menopause; Meta analysis

Indexed keywords

ISOFLAVONE DERIVATIVE; PLACEBO; TUMOR MARKER;

ARTICLE; BREAST CANCER; BREAST DENSITY; BREAST DISEASE; CANCER RISK; CLINICAL TRIAL; COCHRANE LIBRARY; DATA EXTRACTION; DENSITY; DIET SUPPLEMENTATION; DIETARY INTAKE; EMBASE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LETHARGY; MAMMOGRAPHY; MEDLINE; META ANALYSIS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SIDE EFFECT; SKIN DISEASE; SYSTEMATIC REVIEW; VALIDITY; WEIGHT GAIN;

AGE FACTORS; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; ISOFLAVONES; MAMMOGRAPHY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT;

EID: 78649380204     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmq011     Document Type: Article

References (83)

1. Allred CD, Allred KF, Ju YH, Virant SM, Helferich WG. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res 2001;61:5045-5050.
2. Allred CD, Allred KF, Ju YH, Clausen LM, Doerge DR, Schantz SL, Korol DL, Wallig MA, Helferich WG. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats. Carcinogenesis 2004a;25:211-218.
3. Allred CD, Allred KF, Ju YH, Goeppinger TS, Doerge DR, Helferich WG. Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis 2004b;25:1649-1657.
4. Atkinson C, Warren RM, Sala E, Dowsett M, Dunning AM, Healey CS, Runswick S, Day NE, Bingham SA. Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial. Breast Cancer Res 2004;6:R170-R179.
5. Atteritano M, Mazzaferro S, Frisina A, Cannata ML, Bitto A, D'Anna R, Squadrito F, Macri I, Frisina N, Buemi M. Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women. Osteoporos Int 2009; 20:1947-1954.
6. Balk E, Chung M, Chew P, Ip S, Raman G, Kupelnick B, Tatsioni A, Sun Y, Wolk B, DeVine D. et al. Effects of Soy on Health Outcomes. Evidence Report/Technology Assessment No. 126. (Prepared by Tufts-New England Medical Center Evidence-based Practice Center under Contract No. 290-02-0022.) AHRQ Publication No. 05-E024-2.
7. Rockville, MD: Agency for Healthcare Research and Quality, 2005. Becker S, Kaaks R. Exogenous and endogenous hormones, mammographic density and breast cancer risk: can mammographic density be considered an intermediate marker of risk? Recent Results Cancer Res 2009;181:135-157.
8. Boyd NF, Greenberg C, Lockwood GA, Little L, Martin L, Byng J, Yaffe M, Tritchler D. Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. J Natl Cancer Inst 1997;89:488-496.
9. Boyd NF, Martin LJ, Stone J, Greenberg C, Minkin S, Yaffe MJ. Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention. Curr Oncol Rep 2001;3:314-321.
10. Buist DS, Aiello EJ, Miglioretti DL, White E. Mammographic breast density, dense area, and breast area differences by phase in the menstrual cycle. Cancer Epidemiol Biomarkers Prev 2006;15:2303-2306.
11. Cassidy A, Bingham S, Setchell KD, Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994; 60:333-340.
12. Cline JM, Wood CE. Estrogen/isoflavone interactions in cynomolgus macaques (Macaca fascicularis). Am J Primatol 2009;71:722-731.
13. Cummings SR, Tice JA, Bauer S, Browner WS, Cuzick J, Ziv E, Vogel V, Shepherd J, Vachon C, Smith-Bindman R et al. Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst 2009;101:384-398.
14. D'Anna R, Cannata ML, Marini H, Atteritano M, Cancielleri F, Corrado F, Triolo O, Rizzo P, Russo S, Gaudio A et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study. Menopause 2009;16:301-306.
15. Duncan AM, Merz BE, Xu X, Nagel TC, Phipps WR, Kurzer MS. Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab 1999;84:192-197.
16. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997;315:629-634.
17. Endogenous Hormones Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer postmenopausal women: reanalysis of nine prospective studies. J Nat Cancer Inst 2002;94:606-616.
18. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-1886.
19. Greendale GA, Reboussin BA, Stone S, Wasilauskas C, Pike MC, Ursin G. Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 2003;95:30-37.
20. Higgins JPT, Green S. (eds). Cochrane Handbook for Systematic Reviews of Interventions version 5.0.1 [updated September 2008]. The Cochrane Collaboration. 2008a; Available at www.cochrane-handbook.org.
21. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. Br Med J 2003;327:557-560.
22. Hooper L, Ryder JJ, Kurzer MS, Lampe JW, Messina MJ, Phipps WR, Cassidy A. Effects of soy protein and isoflavones on circulating hormone concentrations in pre-and post-menopausal women: a systematic review and meta-analysis. Hum Reprod Update 2009; 15:423-440.
23. Hovhannisyan G, Chow L, Schlosser A, Yaffe MJ, Boyd NF, Martin LJ. Differences in measured mammographic density in the menstrual cycle. Cancer Epidemiol Biomarkers Prev 2009;18:1993-1999.
24. Hsieh CY, Santell RC, Haslem SZ, Helferich WG. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 1998; 58:3833-3838.
25. Ju YH, Allred CD, Allred KF, Karko KL, Doerge DR, Helferich WG. Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J Nutr 2001; 131:2957-2962.
26. Kanno J, Onyon L, Peddada S, Ashby J. The OECD program to validate the rat uterotrophic bioassay. Phase 2: dose-response studies. Environ Health Perspect 2003;111:1530-1549.
27. Kataoka M, Atkinson C, Warren RM, Sala E, Day NE, Highnam R, Warsi I, Bingham SA. Mammographic density using two computer-based methods in an isoflavone trial. Maturitas 2008;59:350-357.
28. Kok L, Kreijkamp-Kaspers S, Grobbee DE, van der Schouw YT. Design and baseline characteristics of a trial on health effects of soy protein with isoflavones in postmenopausal women. Maturitas 2004;47:21-29.
29. Kok L, Kreijkamp-Kaspers S, Grobbee DE, Lampe JW, van der Schouw YT. Soy isoflavones, body composition, and physical performance. Maturitas 2005a;52:102-110.
30. Kok L, Kreijkamp-Kaspers S, Grobbee DE, Lampe JW, van der Schouw YT. A randomized, placebo-controlled trial on the effects of soy protein containing isoflavones on quality of life in postmenopausal women. Menopause 2005b;12:56-62.
31. Korde LA, Wu AH, Fears T, Nomura AM, West DW, Kolonel LN, Pike MC, Hoover RN, Ziegler RG. Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol Biomarkers Prev 2009;18:1050-1059.
32. Kreijkamp-Kaspers S, Kok L, Bots ML, Grobbee DE, Lampe JW, van der Schouw YT. Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women. Am J Clin Nutr 2005;81:189-195.
33. Kreijkamp-Kaspers S, Kok L, Grobbee DE, de Haan EH, Aleman A, Lampe JW, van der Schouw YT. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. J Am Med Assoc 2009;292:65-74.
34. Lamartiniere CA. Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr 2000;71:1705S-1707S.
35. Lamartiniere CA, Murrill WB, Manzolillo PA, Zhang JX, Barnes S, Zhang X, Wei H, Brown NM. Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats. Proc Soc Exp Biol Med 1998;217:358-364.
36. Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R, Elgavish A. Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr 2002;132:552S-558S.
37. Lampe JW. Is equol the key to the efficacy of soy foods? Am J Clin Nutr 2009;89:1664S-1667S.
38. Lesser LI, Ebbeling CB, Goozner M, Wypig D, Ludwig DS. Relationship between funding source and conclusion among nutrition-related scientific articles. PLoS Med 2007;4:e5.
39. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. Br Med J 2003;326:1167-1170.
40. Losel RM, Falkenstein E, Feuring M. Nongenomic steroid action: controversies, questions, and answers. Physiol Rev 2003;83:965-1016.
41. Marini H, Minutoli L, Polito F, Bitto A, Altavilla D, Atteritano M, Gaudio A, Mazzaferro S, Frisina A, Frisina N et al. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Ann Intern Med 2007;146:839-847.
42. Marini H, Bitto A, Altavilla D, Burnett BP, Polito F, Di Stephano V, Minutoli L, Atteritano M, Levy RM, D'Anna R et al. Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study. J Clin Endocrinol Metab 2008;93:4787-4796.
43. Martin LJ, Boyd NF. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res 2008;10:201.
44. Masala G, Assedi M, Ambrogetti D, Sera F, Salvini S, Bendinelli B, Ermini I, Georgi D, Rosselli del Turco M, Palli D. Physical activity and mammographic breast density in a Mediterranean population: the EPIC Florence longitudinal study. Int J Cancer 2009;124:1654-1661.
45. Maskarinec G, Williams AE, Inouye JS, Stanczyk FZ, Franke AA. A randomized isoflavone intervention among premenopausal women. Cancer Epidemiol Biomarkers Prev 2002;11:195-201.
46. Maskarinec G, Williams AE, Carlin L. Mammographic densities in a one-year isoflavone intervention. Eur J Cancer Prev 2003;12:165-169.
47. Maskarinec G, Franke AA, Williams AE, Hebshi S, Oshiro C, Murphy S, Stanczyk FZ. Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women. Cancer Epidemiol Biomarkers Prev 2004a;13:1736-1744.
48. Maskarinec G, Takata Y, Franke AA, Williams AE, Murphy SP. A 2-year soy intervention in premenopausal women does not change mammographic densities. J Nutr 2004b;134:3089-3094.
49. Maskarinec G, Verheus M, Steinberg FM, Amato P, Cramer MK, Lewis RD, Murray MJ, Young RL, Wong WW. Various doses of soy isoflavones do not modify mammographic density in postmenopausal women. J Nutr 2009;139:1-6.
50. McCormack VA, dos Santos Silva I. Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1159-1169.
51. Messina M. The safety and benefits of soybean isoflavones. A natural alternative to conventional hormone therapy? Menopause 2007;14:958.
52. Messina M, Wu AH. Perspectives on the soy-breast cancer relation. Am J Clin Nutr 2009;89:1673S-1679S.
53. Messina M, McCaskill-Stevens W, Lampe JW. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst 2006;98:1275-1284.
54. Messina M, Watanabe S, Setchell KD. Report on the 8th International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment. J Nutr 2009;139:796S-802S.
55. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
56. Penttinen-Damdimopoulou PE, Power KA, Hurmerinta TT, Nurmi T, van der Saag PT, Makela SI. Dietary sources of lignans and isoflavones modulate responses to estradiol in estrogen reporter mice. Mol Nutr Food Res 2009;53:996-1006.
57. Pildal J, Hróbjartsson A, Jørgensen KJ, Hilden J, Altman DG, Gøtzsche PC. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol 2007;36:847-857.
58. Power KA, Saarinen NM, Chen JM, Thompson LU. Mammalian lignans enterolactone and enterodiol, alone and in combination with the isoflavone genistein, do not promote the growth of MCF-7 xenografts in ovariectomized athymic nude mice. Int J Cancer 2006a; 118:1316-1320.
59. Power KA, Ward WE, Chen JM, Saarinen NM, Thompson LU. Genistein alone and in combination with the mammalian lignans enterolactone and enterodiol induce estrogenic effects on bone and uterus in a postmenopausal breast cancer mouse model. Bone 2006b;39:117-124.
60. Power KA, Ward WE, Chen JM, Saarinen NM, Thompson LU. Flaxseed and soy protein isolate, alone and in combination, differ in their effect on bone mass, biomechanical strength, and uterus in ovariectomized nude micewith MCF-7 human breast tumor xenografts. J Toxicol Environ Health A 2007;70:1888-1896.
61. Powles TJ, Howell A, Evans DG, McCloskey EV, Ashley S, Greenhalgh R, Affen J, Flook LA, Tidy A. Red clover isoflavones are safe and well tolerated in women with a family history of breast cancer. Menopause Int 2008;14:6-12.
62. Reeves KW, Stone RA, Modugno F, Ness RB, Vogel VG, Weissfield JL, Habel LA, Sternfeld B, Cauley JA. Longitudinal association of anthropometry with mammographic breast density in the Study of Women's Health Across the Nation. Int J Cancer 2009;124:1169-1177.
63. Review Manager (RevMan) [Computer program]. Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
64. Saarinen NM, Power KA, Chen JM, Thompson LU. Flaxseed attenuates the tumor growth stimulating effect of soy protein in ovariectomized athymic mice with MCF-7 human breast cancer xenografts. Int J Cancer 2009;119:925-931.
65. Seo HS, DeNardo DG, Jacquot Y, Laios I, Vidal DS, Zambrana CR. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha. Breast Cancer Res Treat 2006;99:121-134.
66. Setchell KD, Cassidy A. Dietary isoflavones: Biological effects and relevance to human health. J Nutr 1999;129:758S-767S.
67. Shu XO, Zheng Y, Cai H, Gu K, Chen Z, Zheng W, Lu W. Soy Food Intake and Breast Cancer Survival. J Am Med Assoc 2009;302:2437-2443.
68. Tempfer CB, Froese G, Heinze G, Bentz E-K, Hefler LA, Huber JC. Side Effects of Phytoestrogens: A Meta-analysis of Randomized Trials. Am J Med 2009;122:939-946.
69. Tice JA. Soy for breast ca ncer prevention in high risk pre-menopausal women: Final report for the US Army Medical Research and Material Command. 2006; Storming Media, at www.stormingmediaus/59/5920/A592064html.
70. Tice JA, Guthrie N, Shepherd J, Kerlikowske K, Esserman L. Soy for the Prevention of Breast Cancer-a randomized trial. Era of Hope meeting Baltimore, MD 8-11 June 2005.
71. Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 2006;98:459-471.
72. Ursin G, Parisky YR, Pike MC, Spicer DV. Mammographic density changes during the menstrual cycle. Cancer Epidemiol Biomarkers Prev 2001; 10:141-142.
73. Vachon CM, Van Gils CH, Sellers TA, Ghosh K, Pruthi S, Brandt KR, Pankratz VS. Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res 2007;9:217.
74. Verheus M, Van Gils CH, Kreijkamp-Kaspers S, Kok L, Peeters PHM, Grobbee DE, van der Schouw YT. Soy protein containing isoflavones and mammographic density in a randomized controlled trial in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2009;17: 2632-2638.
75. Walker K, Fletcher O, Johnson N, Coupland B, McCormack VA, Folkerd E, Gibson L, Hillier SG, Holly JM, Moss S et al. Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors. Cancer Res 2009;69:6490-6499.
76. Wang TT, Sathyamoorthy N, Phang JM. Molecular effects of genistein on estrogen receptormediated pathways. Carcinogenesis 1996;17:271-275.
77. White E, Velentgas P, Mandelson MT, Lehman CD, Elmore JG, Porter P, Yasui Y, Taplin SH. Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years. J Natl Cancer Inst 1998;90:906-910.
78. Wolfe JN. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 1976;37:2486-2492.
79. Wood L, Egger M, Gluud LL, SchultzK, Juni P, AltmanDG,GluudC,MartinRM, Wood AJG, Sterne JAC. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. Br Med J 2008;336:601-605.
80. Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 2002;23:1491-1496.
81. Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer 2008;98:9-14.
82. Yaffe MJ. Mammographic density. Measurement of mammographic density. Breast Cancer Res 2008;10:209.
83. Yong M, Atkinson C, Newton KM, iello Bowles EJ, Stanczyk FZ, Westerlind KC, Holt VL, Schwartz SM, Leisenring WM, Lampe JW. Associations between endogenous sex hormone levels and mammographic and bone densities in premenopausal women. Cancer Causes Control 2009;20:1039-1053.